Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Non-Current Debt (2023 - 2025)

Profound Medical has reported Non-Current Debt over the past 3 years, most recently at $4.5 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $4.5 million for Q4 2025, up 53.86% from a year ago — trailing twelve months through Dec 2025 was $4.5 million (up 53.86% YoY), and the annual figure for FY2025 was $4.5 million, up 53.86%.
  • Non-Current Debt for Q4 2025 was $4.5 million at Profound Medical, up from $4.5 million in the prior quarter.
  • Over the last five years, Non-Current Debt for PROF hit a ceiling of $5.0 million in Q4 2023 and a floor of $2.9 million in Q4 2024.
  • Median Non-Current Debt over the past 3 years was $4.5 million (2025), compared with a mean of $4.3 million.
  • Biggest five-year swings in Non-Current Debt: plummeted 41.52% in 2024 and later soared 53.86% in 2025.
  • Profound Medical's Non-Current Debt stood at $5.0 million in 2023, then plummeted by 41.52% to $2.9 million in 2024, then surged by 53.86% to $4.5 million in 2025.
  • The last three reported values for Non-Current Debt were $4.5 million (Q4 2025), $4.5 million (Q2 2025), and $4.5 million (Q1 2025) per Business Quant data.